Pharmacological Therapy for Treatment of Recurrent Central Giant Cell Lesion in a Child.
J Dent Child (Chic)
; 86(2): 113-117, 2019 May 15.
Article
en En
| MEDLINE
| ID: mdl-31395117
ABSTRACT
A central giant cell lesion (CGCL) is a reactive lesion that causes destruction of bone and soft tissues and has a high recurrence rate. Only 16 percent of CGCLs are observed in children. Treatment is determined by the aggressiveness and size of the lesion and it usually involves curettage or resection. Alternative treatments, such as nasal calcitonin and intralesional corticosteroid injections, are also used. The purposes of this paper are (1) to report the case of a nine-year-old patient who presented with a CGCL; (2) to describe its pharmacological management; and (3) to review the literature about the clinical, radiographic, and histological features of CGCL.
Buscar en Google
Colección:
01-internacional
Base de datos:
MEDLINE
Asunto principal:
Granuloma de Células Gigantes
/
Enfermedades Mandibulares
Límite:
Child
/
Humans
Idioma:
En
Revista:
J Dent Child (Chic)
Asunto de la revista:
ODONTOLOGIA
/
PEDIATRIA
Año:
2019
Tipo del documento:
Article
País de afiliación:
Brasil